JF
RNAC icon

Jump Financial’s Cartesian Therapeutics RNAC Stock Holding History

Jump Financial’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$696K Buy
+66,800
New +$495K 0.01% 1344
2023
Q2 		– Sell
-3,053
Closed -$127K – 2109
2023
Q1 		$127K Buy
+3,053
New +$144K 0.01% 1401
2022
Q1 		– Sell
-1,420
Closed -$139K – 1857
2021
Q4 		$139K Buy
+1,420
New +$153K 0.01% 1174
2021
Q1 		– Sell
-2,260
Closed -$205K – 1230
2020
Q4 		$205K Buy
2,260
+1,727
+324% +$150K 0.03% 777
2020
Q3 		$40K Buy
+533
New +$40.8K 0.01% 729

Other funds holding RNAC

Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jump Financial's RNAC Position: Q2 2026 in Review

Jump Financial opened a new position in Cartesian Therapeutics (RNAC) in Q2 2026: 66,800 shares worth $696K. The stake represents 0.01% of the portfolio and ranks #1344 among its holdings. This is a return to the name: Jump Financial previously reported a position in RNAC as recently as Q1 2023.

Jump Financial first reported a position in RNAC in Q3 2020 and has held it in 5 quarters since. 95 funds tracked by Wall St. Rank hold RNAC as of Q2 2026.

  • Jump Financial held 66,800 shares of Cartesian Therapeutics worth $696K as of Q2 2026.
  • Cartesian Therapeutics was a new Jump Financial position in Q2 2026.
  • Cartesian Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1344 holding.
  • Jump Financial first reported a position in Cartesian Therapeutics in Q3 2020 and has held it in 5 quarters since.
  • 95 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.